Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myasthenia Gravis × Mycophenolic Acid × 90 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Myelodysplastic Syndromes 9 Hematologic Neoplasms 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Biphenotypic, Acute 7 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Anemia, Refractory, with Excess of Blasts 5 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 4 Hodgkin Disease 4 Hematologic Diseases 4 Myeloproliferative Disorders 3 Lymphoproliferative Disorders 3 Lymphoma, Mantle-Cell 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, B-Cell 3 Graft vs Host Disease 3 Primary Myelofibrosis 2 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphatic Diseases 2 Leukemia, Prolymphocytic 2 Leukemia, Myeloid 2

Interventions

rozanolixizumab 5 ravulizumab 4 fludarabine 4 Cyclophosphamide 4 zilucoplan 3 telitacicept 3 efgartigimod alfa 3 Prednisone 3 inebilizumab 2 thymoglobulin 1 remibrutinib 1 prednylidene 1 iptacopan 1 eculizumab 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 Tacrolimus 1 Steroids 1 Robotic Surgical Procedures 1 Pyridostigmine Bromide 1 Prednisolone 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Melphalan 1 Etoposide 1 Data Collection 1 Cytarabine 1 Cladribine 1 Carmustine 1 Azathioprine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04182984 2026-01-30

TREAT-OMG

Tang-Du Hospital

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡